Kenvue effort to dismiss Tylenol case rejected by Texas judge
A bid by Kenvue (KVUE) to dismiss a lawsuit brought against it by Texas Attorney General Ken Paxton accusing the company of...
Tag: JNJ
J&J seeks additional indication for Imaavy for rare type of anemia
Johnson & Johnson (JNJ) has submitted a supplemental New Drug Application to the US FDA seeking approval of Imaavy...
Bayer sues Johnson & Johnson over prostate cancer drug claims
New Jersey-based Johnson & Johnson (JNJ) defended its testing and marketing. "Litigation does not change data," a...
Dividend Roundup: Halliburton, AbbVie, Johnson & Johnson, Delta Air Lines, and more
This week's dividend activity included increased payouts from Sherwin-Williams (SHW) and Analog Devices (ADI) as well as...
Johnson & Johnson considering sale of orthopedics business – report
Johnson & Johnson (JNJ) is exploring a sale of its orthopedics business, DePuy Synthes, in a deal that could have a...
J&J to build over $1B cell therapy production site in Pennsylvania
Johnson & Johnson (JNJ) on Wednesday announced plans to construct a cell therapy manufacturing facility in Pennsylvania...
AC Immune says partner J&J pauses enrollment in mid-stage trial for Alzheimer’s drug
AC Immune (ACIU) has disclosed that its partner Janssen Pharmaceuticals of Johnson & Johnson (JNJ) has temporarily...
J&J gains monthly dosing approval for Rybrevant Faspro
The U.S. FDA has granted approval for a monthly dosing of Johnson & Johnson's (JNJ) Rybrevant Faspro (amivantamab and...
J&J hit with $250K jury verdict in Philadelphia talc powder case
A jury in a Philadelphia court found Johnson & Johnson liable for a woman developing ovarian cancer after using the...
Coherus, J&J agree to evaluate combination prostate cancer treatment
Johnson & Johnson (JNJ) has agreed to supply Coherus Oncology (CHRS) with its bispecific antibody pasritamig to...